Unique ID issued by UMIN | UMIN000015588 |
---|---|
Receipt number | R000018116 |
Scientific Title | A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin |
Date of disclosure of the study information | 2014/12/24 |
Last modified on | 2020/11/06 13:52:38 |
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin (P-GDM-Lina)
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin (P-GDM-Lina)
Japan |
Patients scheduled administration of glucocorticoid
Medicine in general | Nephrology | Clinical immunology |
Others
NO
To investigate the efficacy and safety for prevention of glucocorticoid induced diabetes mellitus by linagliptin
Safety,Efficacy
Proportion of development of glucocorticoid induced diabetes mellitus within 1 month
Concomitant insulin use
Concomitant anti-diabetic drug
Adverse effect
Change in HbAic
Change in HOMA-IR
Change in glycoalbumin
Change in 1.5-AG
Change in adiponectin
Change in glucagon
Change in cortisol
Change in leptin
Change in serum and urine CPR
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
Concomitant administration of linagliptin at start of GC administration
20 | years-old | <= |
Not applicable |
Male and Female
1) Administration of 20mg/day or more of prednisone is scheduled
2) Not fulfilled below criteria for diabetes mellitus
a) HbA1c >= 6.5 %
b) fasting blood glucose level >= 126 mg/dL
c) blood glucose level at 2hr on OGTT >= 200mg/dL or casual blood glucose level >= 200mg/dL
3) At least either one of following risk factor for glucocorticoid induced diabetes mellitus
a) eGFR =< 60ml/min/1.73m2
b) 65 year or older
c) HbA1c > 6.0 %
4) Informed consent is obtained
1) < 20 years old
2) Inability of internal use
3) Pregnancy
4) Glucocorticoid pulse therapy is scheduled
5) Malignancy
17
1st name | Ken-ei |
Middle name | |
Last name | Sada |
Department of Nephrology, Rheumatology, Endocrinology and Metabolism,
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan
086-235-7235
sadakenn@okayama-u.ac.jp
1st name | Yoshia |
Middle name | |
Last name | Miyawaki |
Okayama University Graduate Schoolof of Medicine, Dentistry and Pharmaceutical Sciences
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan
086-235-7235
yoshia0316@gmail.com
Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
None
Self funding
Okayama University
2-5-1 Shikata-cho, Kita-ku, Okayama
86-235-7361
ouh-crrb@adm.okayama-u.ac.jp
NO
岡山大学病院
2014 | Year | 12 | Month | 24 | Day |
Unpublished
Completed
2014 | Year | 12 | Month | 24 | Day |
2014 | Year | 12 | Month | 24 | Day |
2014 | Year | 12 | Month | 24 | Day |
2016 | Year | 02 | Month | 28 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 04 | Month | 30 | Day |
2016 | Year | 10 | Month | 31 | Day |
2014 | Year | 11 | Month | 02 | Day |
2020 | Year | 11 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018116